In partnership with

Why Most AI Spending Isn’t Paying Off

Generative AI has captured the imagination of enterprises everywhere, driving a surge in investment. By mid-2025, companies had poured tens of billions of dollars into AI pilots, vendor contracts, and integrations. Yet despite this enthusiasm, the vast majority of organizations 95% aren’t seeing meaningful returns, according to recent studies.

Known as the GenAI Divide, this gap separates a small group capturing significant value from the majority stuck with stalled projects that don’t impact the bottom line.

On the surface, AI adoption seems widespread. Most organizations have trialed popular AI tools, and many have deployed them across teams. But this adoption rarely translates into financial gains. Productivity improvements at an individual level such as faster email drafts or research fail to scale into measurable business outcomes. Enterprise-grade AI solutions face even tougher hurdles, with many projects faltering before reaching production due to integration challenges or AI that can’t learn and adapt within complex workflows.

Four key factors drive this divide:

• Only select sectors like Technology and Media have seen deep transformation from GenAI.

• Larger organizations launch more pilots but struggle to scale, whereas mid-sized companies often realize better ROI.

• Budgets tend to favor visible sales and marketing initiatives, which often deliver lower returns than back-office automation.

• Successful collaborations with external partners outperform internal AI builds.

At the heart of the problem is a lack of adaptive learning most AI tools still don’t evolve with user feedback or business workflows.

Counterpoint: AI’s Tangible Success Stories

Yet the picture isn’t all bleak. An increasing body of evidence suggests that, when managed and targeted effectively, generative AI is delivering material returns for many organizations especially those with a clear strategic vision.

• Nearly three in five organizations worldwide are already using generative AI, with 92% of early adopters saying their initiatives have paid for themselves and many reporting an average ROI of 41%.

• Case studies show major efficiency improvements, such as JPMorgan Chase reducing fraud losses by 20%, Walmart lowering stockouts by 30%, and UnitedHealth Group automating 50% of claims processing.

• Generative AI has led to an average performance improvement of 66%, with even greater gains for complex tasks and customer service automation.

• Microsoft reports over 1,000 documented enterprise AI success stories, from financial services to logistics and healthcare, with quantifiable gains in productivity, accuracy, and customer experience.

• Deloitte research finds that almost three-quarters of companies say their most advanced AI projects have met or exceeded ROI targets, with about 20% seeing returns over 30%.

The Bottom Line

The billions invested in GenAI reveal a nuanced landscape: while adoption alone doesn’t guarantee success, a growing share of enterprises are demonstrating that targeted, adaptive deployments can drive real business impact. Evidence is building that AI spending pays off for those who invest in integration, outcome-driven strategies, and ongoing learning narrowing the GenAI Divide with each success story.

Deeptech Nexus // October 8th // San Francisco  

Smack-dab in the middle of SFtech week - A collaborative effort with Crusoe, HPE, NVIDIA, Omni Ventures, Virta Ventures, HPE and IgniteGTM— brought together an extraordinary crowd of deep-tech operators, investors, and innovators. The quality of conversation was off the charts — real signal, no noise.

Hats off to our friend Sebastian Spitzer, who weaved together this group together for an evening that balanced substance and connection. Two powerful panels explored how Physical AI is shaping the future — from sustainable compute and infrastructure to robotics, energy, and automotive innovation.

Ageless Summit // October 10th // Mountain View  

Ageless Evolution Longevity Summit is a powerful reminder of just how quickly the longevity movement is accelerating. A dynamic mix of thought leaders, clinicians, investors, and technologists came together not just to talk, but to design what “longer, better lives” can truly look like.

From Daniel Kraft to Dr. Wei-Wu He, Dr. Aubrey de Grey, and many more, the speaker lineup delivered inspiration and depth in equal measure. The conversations were great, and lots of ecosystem builders in attendance (it was like a reuinon of superfriends), a breath of fresh air in the business of the AI ERA.

Hats off to our friends Nick & Sandra Larson for an incredible production. The venue was stunning, the branding vibrant, and the experience flawlessly executed. Amazing to see this partner community continue to grow — we’re rooting for your success. 👏

AI INFRA SUMMIT: Where the Builders Unite

AI INFRA SUMMIT on November 7, 2025, in San Francisco. We’re convening the visionaries, operators, and doers: from hyperscalers to disruptive startups, energy giants to AI-first leaders. Together, we’ll problem-solve, benchmark, and set the priorities for next-generation AI infrastructure.

Bay Area Startups Collectively Secured $2.15B in October MTD

Bay Area startups closed on $1.13B in fundings this week, bringing the October total to $2.15. There were just two megadeals this week, a Series A for Expedition Therapeutics and a Series E for EvenUp.

IPO Watch: Filings keep coming out – Evommune, BillionToOne and MapLight Therapeutics filed this week - but no company has completed their IPO since the government shutdown began. This week the SEC announced that companies can use a little-known automatic approval process to move forward with their IPOs while the shutdown continues, even to the extent of skipping the pricing information. Substantive changes to existing filings are not permitted, however. More...

The Venture Market Report for Q2 & H1 2025 is now available for online browsing or download. It focuses on startups in Silicon Valley and Northern California and provides an in-depth look at the state of our startup ecosystem. The data for the Venture Market Report comes directly from the Pulse of the Valley weekday newsletter and summarizes fundings by sector and series, acquisitions and IPOs (with details) plus new funds raised by investors and new VC firms launched. Check it out and sign up for a 1 week free trial of the Pulse if you'd like to get the data when it first comes out.

For startups raising capital: The Pulse of the Valley weekday newsletter keeps you current with the startups that are getting funded and who's investing in them – and not just the big, high profile deals. We surface the 50% of early stage fundings – and their investors - that close quietly and never hit the press. Details include investor and executive connections and contact information on 25+ years of fundings and business activity. Founders get the full $50/month package for just $7/month with LinkSV's Entrepreneur membership, details and signup here.

Follow us on LinkedIn to stay on top of what's happening in 2025 in startup fundings, M&A and IPOs, VC fundraising plus new executive hires & investor moves.

Early Stage:

• Expedition Therapeutics closed a $165M Series A, a biotechnology company developing novel therapies for serious inflammatory and respiratory diseases, including COPD.

• Remedy Robotics closed a $35M Series A, we exist to bring flawless, immediate, endovascular intervention (EI)—treatment for stroke, heart attack, bleeding, aneurysmal disease, pulmonary embolism and more— to every patient worldwide.

• FurtherAi closed a $25M Series A with $30M, the AI workspace purpose-built for insurance.

• Oath Surgical closed a $24M Series A, building the future of surgical care: surgeon-led, AI-powered, and value-based by design - the first vertically integrated system combining AI software and tech-first surgical centers.

• Composite Sciences closed a $5.6M Seed, an agent for your browser, it's the best way to get work done in your browser.

Growth Stage:

• EvenUp closed a $150M Series E, on a mission to close the justice gap with AI-powered technology that empowers personal injury firms to deliver higher standards of representation and fairer outcomes for millions of injury victims.

• Meanwhile closed a $82M Series B, helps you protect your family, as the first and only life insurance company denominated in Bitcoin.

• Blue Current closed a $81M Series D, driving a revolution in the battery industry with its safe, energy dense, solid-state battery.

• David AI closed a $50M Series B, provides proprietary training data for Audio AI, powering leading AI models through sourcing, generating, and labeling high-quality, non-publicly-available audio datasets.

• Snappr closed a $28M Series B, the one-stop-shop for visual content creation.

An Appreciation to our Community Partners 🌻 

Your Feedback Matters!

Your feedback is crucial in helping us refine our content and maintain the newsletter's value for you and your fellow readers. We welcome your suggestions on how we can improve our offering. [email protected] 

Logan Lemery
Head of Content // Team Ignite

Typing is a thing of the past

Typeless turns your raw, unfiltered voice into beautifully polished writing - in real time.

It works like magic, feels like cheating, and allows your thoughts to flow more freely than ever before.

With Typeless, you become more creative. More inspired. And more in-tune with your own ideas.

Your voice is your strength. Typeless turns it into a superpower.

Download for Mac today